Kamyar Kalantar-Zadeh M.D. to Anemia
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Anemia.
Connection Strength
6.015
-
Burden of Anemia in Chronic Kidney Disease: Beyond Erythropoietin. Adv Ther. 2021 01; 38(1):52-75.
Score: 0.683
-
Association of Pre-End-Stage Renal Disease Hemoglobin with Early Dialysis Outcomes. Am J Nephrol. 2018; 47(5):333-342.
Score: 0.576
-
Understanding the Recent Increase in Ferritin Levels in United States Dialysis Patients: Potential Impact of Changes in Intravenous Iron and Erythropoiesis-Stimulating Agent Dosing. Clin J Am Soc Nephrol. 2015 Oct 07; 10(10):1814-21.
Score: 0.476
-
Is iron maintenance therapy better than load and hold? J Am Soc Nephrol. 2013 Jun; 24(7):1028-31.
Score: 0.410
-
Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients. Nephrol Dial Transplant. 2013 Jul; 28(7):1936-45.
Score: 0.391
-
Darbepoetin alfa and chronic kidney disease. N Engl J Med. 2010 Feb 18; 362(7):654; author reply 655.
Score: 0.325
-
Iron therapy in chronic kidney disease: current controversies. J Ren Care. 2009 Dec; 35 Suppl 2:14-24.
Score: 0.321
-
Review article: Biomarkers of clinical outcomes in advanced chronic kidney disease. Nephrology (Carlton). 2009 Jun; 14(4):408-15.
Score: 0.310
-
Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients. Am J Kidney Dis. 2009 May; 53(5):823-34.
Score: 0.306
-
Hemoglobin variability in anemia of chronic kidney disease. J Am Soc Nephrol. 2009 Mar; 20(3):479-87.
Score: 0.303
-
Combined high serum ferritin and low iron saturation in hemodialysis patients: the role of inflammation. Clin J Am Soc Nephrol. 2008 Nov; 3(6):1691-701.
Score: 0.296
-
Association of anemia with outcomes in men with moderate and severe chronic kidney disease. Kidney Int. 2006 Feb; 69(3):560-4.
Score: 0.246
-
Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr. 2004 Aug; 80(2):299-307.
Score: 0.222
-
Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis. 2003 Oct; 42(4):761-73.
Score: 0.209
-
History of Erythropoiesis-Stimulating Agents, the Development of Biosimilars, and the Future of Anemia Treatment in Nephrology. Am J Nephrol. 2017; 45(3):235-247.
Score: 0.132
-
New Options for Iron Supplementation in Maintenance Hemodialysis Patients. Am J Kidney Dis. 2016 Mar; 67(3):367-75.
Score: 0.121
-
Serum phosphorus and association with anemia among a large diverse population with and without chronic kidney disease. Nephrol Dial Transplant. 2016 04; 31(4):636-45.
Score: 0.119
-
Iron indices and survival in maintenance hemodialysis patients with and without polycystic kidney disease. Nephrol Dial Transplant. 2013 Nov; 28(11):2889-98.
Score: 0.105
-
Associations of pre-transplant anemia management with post-transplant delayed graft function in kidney transplant recipients. Clin Transplant. 2012 Sep-Oct; 26(5):782-91.
Score: 0.094
-
Erythropoietin in kidney disease and type 2 diabetes. N Engl J Med. 2011 01 27; 364(4):384-5; author reply 385-6.
Score: 0.087
-
Epoetin dosing and dialysis facility ownership. JAMA. 2007 Aug 22; 298(8):862; author reply 862-3.
Score: 0.068
-
Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol. 2006 Apr; 17(4):1181-91.
Score: 0.062
-
Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients. Nephrol Dial Transplant. 2004 Jan; 19(1):141-9.
Score: 0.053
-
Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis. 2003 Nov; 42(5):864-81.
Score: 0.053
-
A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001 Dec; 38(6):1251-63.
Score: 0.046